1. 刘允怡 中国 香港中文大学 中国科学院院士 Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase ..
2. Lowell, Bradford B. 美国 Harvard Medical School 2023美国科学院院士 Human CIDEC transgene improves lipid metabolism and protects against high-fat diet-induced glucose i..
3. 张运 中国 山东大学 中国工程院院士 Single nucleotide polymorphisms in CIDEC gene are associated with metabolic syndrome components risk..
4. Reig, Maria 西班牙 University of BARCELONA Systemic therapies in hepatocellular carcinoma: A revolution?
5. Timothy M,Pawlik 美国 OHIO STATE University Cost effectiveness of immune checkpoint inhibitors for treatment of Hepatocellular Carcinoma: A syst..
6. Mark J,Ratain 美国 University of Chicago Combining atezolizumab 1200 mg with bevacizumab 15 mg/kg: based on science or just revenues?
7. Jean-Pierre,Brion 比利时 Universite Libre de Bruxelles Loss of Ephaptic Contacts in the Murine Thalamus during Osmotic Demyelination Syndrome
8. 杨顺发 中国 台湾中山医学大学 Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Tr..
9. Annamaria,Staiano 意大利 University of Naples Federico II UPDATE-2022 Italian guidelines on the management of bronchiolitis in infants
10. Paolo,Manzoni 意大利 St Anna Hospital UPDATE-2022 Italian guidelines on the management of bronchiolitis in infants
11. Susanna,Esposito 意大利 University of Parma UPDATE-2022 Italian guidelines on the management of bronchiolitis in infants
12. Eugenio,Baraldi 意大利 University of PADUA UPDATE-2022 Italian guidelines on the management of bronchiolitis in infants
13. Mitsuo,Shimada 日本 University of Tokushima Curcumin-Mediated Resistance to Lenvatinib via EGFR Signaling Pathway in Hepatocellular Carcinoma
14. Goel, Ajay 美国 Baylor University Curcumin-Mediated Resistance to Lenvatinib via EGFR Signaling Pathway in Hepatocellular Carcinoma
15. Jean-Luc,Raoul 法国 Institut Paoli-Calmettes New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunoth..
16. Luregn J,Schlapbach 澳大利亚 University of Queensland ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically i..
17. Jean-Jacques,Parienti 法国 CAEN University Hospital ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically i..
18. Antonio,Gasbarrini 意大利 University of Cattolica Sacro Cuore Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellu..
19. Peter,Bartenstein 德国 University of Munich Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellu..
20. Bruno,Sangro 西班牙 University of Navarra Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellu..